Lipid Panel (Cholesterol, HDL, LDL, Triglycerides)
The standard cholesterol workup: total cholesterol, HDL-C, LDL-C, VLDL and triglycerides.
The baseline cardiovascular screen — and the panel most disrupted by androgen use. Necessary but not sufficient; ApoB adds the particle count that LDL-C alone can miss.
Check a Lipid Panel (Cholesterol, HDL, LDL, Triglycerides) result against this range →
What Lipid Panel (Cholesterol, HDL, LDL, Triglycerides) actually measures — the analyte, and the assay
Five numbers, and only three of them were measured. Total cholesterol and triglycerides come off enzymatic assays; HDL cholesterol comes off a homogeneous direct method. LDL cholesterol and VLDL cholesterol are usually calculated, and everything difficult about this panel lives in that calculation.
The Friedewald equation subtracts HDL cholesterol and an estimate of VLDL cholesterol from the total, and it estimates VLDL cholesterol as the triglyceride concentration divided by five. That divisor is a fixed assumption about how much cholesterol a triglyceride-rich particle carries, and the assumption stops holding as triglycerides rise. Among 111,939 patients with high triglycerides — mean age 52, 65.0% male — a Friedewald LDL-C classified the patient correctly 19.3% of the time. The extended Martin/Hopkins method, which uses an adjustable divisor rather than a fixed one, reached 62.1%; the Sampson-NIH equation reached 40.4% Sajja 2021. Four in five Friedewald results were wrong in the group where the answer mattered most.
This is not a fringe finding. The three equations have been validated head to head against each other Erturk Zararsiz 2022, and the Sampson-NIH formula has been assessed specifically in familial combined hyperlipidemia, the phenotype that combines high triglycerides with high apoB Zubiran 2023. Ask which equation your laboratory uses. It is printed nowhere and it changes your LDL-C without changing your blood.
The triglyceride assay has its own quiet defect. It works by releasing glycerol from triglyceride with a lipase and measuring the glycerol — so any free glycerol already in the sample is counted as triglyceride unless the method blanks for it, and many do not. A published case makes the size of that vivid: a patient with a glycerol kinase gene variant carried free glycerol at 40.24 mg/dL (4.37 mmol/L) against a reference of 0.03–0.13 mmol/L, and correcting for it cut the apparent triglyceride concentration by up to 71% Larouche 2025.
Lipid Panel (Cholesterol, HDL, LDL, Triglycerides): what changes the blood, and what only changes the reading
What changes the lipids in your blood — ranked, and note how differently the components behave:
- A recent meal, for triglycerides only. Triglycerides rise after eating and the size of the rise varies widely between people; the determinants of the postprandial response have been measured directly in overweight and obese adults Wilson 2021. Total cholesterol, HDL-C and apoB barely move.
- Alcohol. The fastest large mover of triglycerides in ordinary life, and its effect is days, not months.
- Insulin resistance and visceral fat, which raise triglycerides and lower HDL cholesterol together — the pairing behind the triglyceride-to-HDL ratio.
- Genetics, from familial hypercholesterolemia at one end to the lipoprotein lipase pathway disorders that produce extreme triglycerides at the other.
- Hypothyroidism, nephrotic syndrome, uncontrolled diabetes, pregnancy and oral estrogen, all of which raise one or more components by distinct mechanisms.
- Androgens, especially oral 17-alpha-alkylated compounds, which suppress HDL cholesterol hard.
- Drugs — statins, ezetimibe and fibrates downward; corticosteroids, isotretinoin, some antipsychotics and protease inhibitors upward.
What changes only the reading — and on this panel that list is unusually powerful:
- Which LDL-C equation was applied. The largest single term at high triglycerides, by a wide margin Sajja 2021.
- Free glycerol that was never blanked, which manufactures a triglyceride elevation out of nothing Larouche 2025.
- A lipemic specimen. Severe turbidity interferes with several assays, and laboratories reject such samples — a published case describes a diagnosis of extreme hypertriglyceridemia delayed precisely because the lipemic sample was rejected rather than investigated Van Elslande 2021.
- Fasting state. Not the disaster it is usually presented as for cholesterol, and genuinely important for a calculated LDL-C, because the calculation takes triglycerides as an input Nordestgaard 2016 Sajja 2021.
- Posture and tourniquet time. Standing and prolonged venous stasis concentrate plasma proteins and lipoproteins, raising every component by a few per cent for no biological reason.
Reference interval or decision threshold — which kind of number Lipid Panel (Cholesterol, HDL, LDL, Triglycerides) is
Almost every number on this panel is a decision threshold presented in the typography of a reference interval. 'Total <200, LDL-C <100, HDL-C >40' are not the middle 95% of anybody. They are cut-points chosen because event rates rise above them — the joint European consensus that made fasting optional simultaneously set out desirable concentration cut-points for flagging results, which is an explicit statement that these are risk boundaries and not population descriptions Nordestgaard 2016.
The triglyceride thresholds deserve to be stated with their real outcome data attached, because the everyday numbers and the dangerous numbers are far apart. In 1,530,411 people in a linked electronic health record study, severe hypertriglyceridemia — above 10 mmol/L, roughly 885 mg/dL — occurred in 3,289 individuals, 0.21% of the cohort. Above 20 mmol/L (about 1,770 mg/dL) the hazard ratio for acute pancreatitis was 13.55 (95% CI 9.15–20.06) and for chronic pancreatitis 25.19 (14.91–42.55) Patel 2022. The conventional 150 mg/dL line is a cardiometabolic flag; the pancreatitis risk lives an order of magnitude higher. Both facts belong on the same page, and conflating them is how a triglyceride of 200 becomes an emergency in somebody's head.
HDL cholesterol is the odd one out and should be read as a risk marker rather than a target: it predicts events and has repeatedly failed to behave as something worth raising pharmacologically. And the LDL-C threshold carries the caveat the assay section gives — a threshold applied to a number that was 19.3% accurate in the relevant population is a threshold applied to noise Sajja 2021.
How you would know your Lipid Panel (Cholesterol, HDL, LDL, Triglycerides) was wrong — and when to redraw
Different components have different clocks, and one retest interval for the panel is wrong. Triglycerides respond to alcohol and carbohydrate within days and carry the largest within-person variation on the panel, so a single raised triglyceride is a reason to repeat rather than a result. LDL cholesterol and apoB track a particle pool that turns over in days and reaches a new steady state in about six weeks, which is why six to eight weeks is the interval after starting or changing a lipid-lowering drug.
Conditions that must match, or the comparison is not one: the same laboratory and the same LDL-C equation; the same fasting state, since the calculation inherits the triglyceride Nordestgaard 2016; no alcohol in the preceding few days; at least four to six weeks clear of acute illness or surgery; and the same posture and a short tourniquet time.
What would have to change for the retest to mean something. The internal consistency check is non-HDL cholesterol, which is total minus HDL and involves no assumption at all. If LDL-C has moved and non-HDL-C has not, the equation changed and you did not. If both moved and apoB did not, the particles changed composition rather than number. Only when LDL-C, non-HDL-C and apoB move together has the atherogenic burden actually changed.
How you would know the value was wrong. A triglyceride concentration far out of keeping with the clinical picture, in someone who is not diabetic, not drinking and not pregnant, should prompt a request for a glycerol-blanked method before any treatment is started Larouche 2025. A specimen described as lipemic should be re-drawn fasting and investigated rather than discarded Van Elslande 2021. And an LDL-C that looks impossibly low with a high triglyceride is the classic Friedewald failure — the confirmatory test is a direct apoB Sajja 2021.
What Lipid Panel (Cholesterol, HDL, LDL, Triglycerides) cannot tell you
LDL-C is a mass, not a count, and the two come apart. The panel tells you how much cholesterol is being carried, not how many particles are carrying it, and the discrepancy is largest in exactly the people who look reassuring on this panel: high triglycerides, low HDL, an unremarkable LDL-C. A normal LDL-C alongside a high apoB is not normal risk.
A calculated LDL-C is not valid at high triglycerides, and the failure is not marginal Sajja 2021.
The LDL-C includes cholesterol that is not on LDL. Lp(a)-cholesterol has been measured directly at 0.6 to 35.0 mg/dL, amounting to between 5.8% and 57.3% of reported LDL-C Yeang 2021. Part of what a statin is being asked to lower on this line is a particle it does not act on.
The triglyceride-to-HDL ratio is a convenience, not a measurement. It is a reasonable pointer toward insulin resistance in some populations and performs differently across ancestral groups; it is not a substitute for a fasting insulin or an HbA1c, and it inherits every preanalytical problem the triglyceride has.
None of it tells you whether you have plaque. The panel measures exposure. Whether that exposure has already produced disease is an imaging question.
The wrong inference readers actually draw is that a green-flagged lipid panel closes the cardiovascular question. It closes the cholesterol-mass question on an estimate whose accuracy depends on a triglyceride, in a person whose particle count has not been measured and whose Lp(a) has never been tested.
Sources read for these sections
- Sajja A, et al. Comparison of Methods to Estimate Low-Density Lipoprotein Cholesterol in Patients With High Triglyceride Levels. JAMA Network Open 2021 · PMID 34709388
- Erturk Zararsiz G, et al. Validation of Friedewald, Martin-Hopkins and Sampson low-density lipoprotein cholesterol equations. PLoS One 2022 · PMID 35559957
- Zubiran R, et al. Performance of the enhanced Sampson-NIH equation for VLDL-C and LDL-C in a population with familial combined hyperlipidemia. Atherosclerosis 2023 · PMID 37984194
- Nordestgaard BG, et al. Fasting is not routinely required for determination of a lipid profile. European Heart Journal 2016 · PMID 27122601
- Patel RS, et al. Elevated plasma triglyceride concentration and risk of adverse clinical outcomes in 1.5 million people: a CALIBER linked electronic health record study. Cardiovascular Diabetology 2022 · PMID 35681241
- Larouche M, et al. Glycerol Kinase Gene Variant as a Cause of Pseudohypertriglyceridemia and Apparent Poor Response to Plozasiran. JCEM Case Reports 2025 · PMID 40642335
- Van Elslande J, et al. Delayed diagnosis and treatment of extreme hypertriglyceridemia due to rejection of a lipemic sample. Biochemia Medica 2021 · PMID 33927560
- Wilson SM, et al. Determinants of the postprandial triglyceride response to a high-fat meal in healthy overweight and obese adults. Lipids in Health and Disease 2021 · PMID 34544430
- Yeang C, et al. Novel method for quantification of lipoprotein(a)-cholesterol: implications for improving accuracy of LDL-C measurements. Journal of Lipid Research 2021 · PMID 33636163
The plan of attack
In this order. Most people start at step four, which is why they change five things at once and learn nothing.
- Confirm the number is real
Fasting vs non-fasting. Triglycerides rise substantially after eating; total and HDL cholesterol barely move. Because LDL is usually calculated from triglycerides, a non-fasted draw distorts the LDL too — and the error is worst in exactly the people with high triglycerides. Fast 10–12 hours if LDL matters. Guidelines increasingly accept non-fasting lipids, but be consistent between tests. - Read it with its partner
Fast 9–12h for accurate triglycerides (LDL-C is calculated from them). Draw it alongside: ApoB (Apolipoprotein B), Lipoprotein(a) — Lp(a), Fasting Insulin. - Work out which direction is yours
If it's high — High LDL/ApoB drives atherosclerosis. High triglycerides above ~500 mg/dL also risks pancreatitis.
If it's low — Very low HDL is common on androgens and associated with elevated risk. Very low LDL is generally fine and often therapeutic. - Fix it in this order
Nutrition. Triglycerides respond fast — cut refined carbohydrate, added sugar (especially fructose) and alcohol; results often show in weeks. For LDL/ApoB: reduce saturated fat, add soluble fiber.
Lifestyle. Aerobic exercise raises HDL and lowers triglycerides; fat loss improves everything; stop smoking; moderate alcohol sharply.
Supplements. Omega-3 (EPA/DHA) meaningfully lowers triglycerides. Berberine, psyllium and plant sterols for LDL. Niacin raises HDL but lacks outcome benefit.
Hormones. Statins/ezetimibe for LDL. Note oral androgens are uniquely damaging to lipids — injectables are far gentler.
Compounds. Triglyceride:HDL ratio is a free insulin-resistance readout hiding inside a $9 test. On any androgen protocol expect HDL suppression — track ApoB alongside.
Work down the list, not across it. Adding a compound on top of an unfixed diet is why generic protocols fail. - Retest
Every 3–6 months on androgens; annually otherwise. Change one thing at a time, or the retest can't tell you which thing worked.
How to fix it
📚 2026 AHA/ACC Guideline on the Management of Dyslipidemia.
This page can tell you what could have made your Lipid Panel (Cholesterol, HDL, LDL, Triglycerides) wrong. It cannot tell you whether it did.
Everything above is free and stays free — the assay, what changes the reading rather than the blood, the retest window and the sources. What no page can do is look at your draw: which laboratory ran it, at what hour, what you were taking that week, and what else was flagged beside it. Every one of those changes the answer, and none of them is on any page. Bringing a real result to people who know that list is what the members' area is for.
Bring your result — $10/mo →🩸 Test your Lipid Panel (Cholesterol, HDL, LDL, Triglycerides)
Order directly through Marek Diagnostics — no doctor's visit needed, drawn at any Quest location in the US. Code CAMERON applies 10% off automatically.
Order this test — 10% off → Browse all 103 markers →What Lipid Panel (Cholesterol, HDL, LDL, Triglycerides) is usually tested alongside
One marker is a data point. These panels add the markers that make Lipid Panel (Cholesterol, HDL, LDL, Triglycerides) interpretable, name why each is on the list, and load the set into your cart at 10% off.
includes this + 8 more markers — Anyone over 30, anyone with a family history of early heart disease, or anyone who's been told their cholesterol is 'fine' and wants to know what that actually means.
includes this + 7 more markers — Weight that won't shift, energy crashes after meals, expanding waistline, family history of diabetes, or a fasting glucose that's crept into the 90s.
What people use Lipid Panel (Cholesterol, HDL, LDL, Triglycerides) to decide
Nobody orders a test for its own sake. Lipid Panel (Cholesterol, HDL, LDL, Triglycerides) is on the test list for these pathways — each one links to what the pathway claims, and what its test list is read for before you spend anything on it.
ApoB counts atherogenic particles; LDL-C estimates the cholesterol inside them. When the two disagree — common in insulin resistance — ApoB is right and LDL-C is falsely reassuring.
This is the pathway with the clearest test. Fasting insulin above roughly 8 µIU/mL, triglyceride:HDL above 2, or raised uric acid all point at insulin resistance — and if that's your picture, this pathway outranks every other one on the page for you specifically.
These are the numbers with real causal mortality evidence. ApoB beats LDL-C, Lp(a) is genetic and worth measuring exactly once in your life, and cystatin-C catches kidney decline that creatinine misses. If you test nothing else on this page, test these.
Metabolic flexibility — the ability to run on fat when carbohydrate runs out — tracks with insulin sensitivity. If HbA1c is creeping up, you are glucose-dependent, and that is the wall you keep hitting.
Lipid Panel (Cholesterol, HDL, LDL, Triglycerides) is also on the test list for these, where it narrows the picture rather than settling it:
What moves your Lipid Panel (Cholesterol, HDL, LDL, Triglycerides)
12 compounds and 2 supplements in the Vault have a documented effect on this marker, or are a reason to have measured it first:
Browse all 278 compounds & 371 supplements →
Would you feel it? Symptoms Lipid Panel (Cholesterol, HDL, LDL, Triglycerides) helps explain
People search for how they feel, not for a marker. These are the complaints where this one is worth checking, and whether it is first-line or a follow-up.
Why your Lipid Panel (Cholesterol, HDL, LDL, Triglycerides) might be wrong
Most abnormal results are interference, not disease. Check these before you change anything. Each says whether the number is wrong (repeat it), badly timed (redraw it), or real with a cause.
Triglycerides rise substantially after eating; total and HDL cholesterol barely move. Because LDL is usually calculated from triglycerides, a non-fasted draw distorts the LDL too — and the error is worst in exactly the people with high triglycerides.
Fast 10–12 hours if LDL matters. Guidelines increasingly accept non-fasting lipids, but be consistent between tests.
Cholesterol falls during acute illness and can stay low for weeks — a lipid panel after a hospital admission understates your true level.
Wait six weeks after any significant illness or surgery.
Active fat loss mobilizes lipids and can transiently raise LDL. Some people show a striking LDL rise on ketogenic diets.
Measure at weight stability, not mid-cut.
Lower HDL substantially, and oral 17-alpha-alkylated compounds do so dramatically.
Expect it on TRT; note it rather than being alarmed by it in isolation.
What Lipid Panel (Cholesterol, HDL, LDL, Triglycerides) means in combination
One marker tells you a little; combinations tell you the story. These are the named patterns this one takes part in.
Classic compensated insulin resistance. Your pancreas is working overtime to keep glucose normal — so the standard screening tests look fine while the underlying problem builds.
This is the most reversible stage. Fat loss, resistance training, post-meal walks, fiber, reduced refined carbohydrate. Consider berberine or inositol; metformin/GLP-1 if clinically appropriate.
Metabolic dysfunction-associated fatty liver — now the most common liver disease there is. It gets dismissed as "slightly high liver enzymes" for years while fibrosis accumulates silently.
5–10% body weight loss meaningfully reduces liver fat and is the single highest-yield intervention. Cut alcohol and fructose, raise protein. If ALT has been up for months, an ELF score answers "is there actual scarring" without a biopsy.
Insulin resistance reduces uric acid excretion by the kidney. So a raised urate is very often a metabolic signal arriving before anyone has a painful toe.
Treat the insulin resistance and urate usually follows. Cut fructose and alcohol (beer especially). Do not start urate-lowering drugs off one reading — that is a clinical decision with its own trade-offs.
The single most under-monitored consequence of androgen use. Androgens — especially oral 17-alpha-alkylated compounds — suppress HDL dramatically and raise ApoB. There are no symptoms; the cost is cumulative arterial damage measured in decades.
Prefer injectables over orals and minimize oral duration. Add cardio, soluble fiber, omega-3s. Many long-term users treat ApoB pharmacologically (statin/ezetimibe) with a physician — that's a rational trade if you're committed to being on hormones for years. Track ApoB every 3 months, not just a standard lipid panel.
What to test next
These put Lipid Panel (Cholesterol, HDL, LDL, Triglycerides) in context — each with its own full breakdown.
Frequently asked questions
Total <200 · LDL-C <100 · HDL-C >40 · Triglycerides <150 mg/dL. Ranges vary by laboratory and assay — always compare to the range printed on your own report.
LDL-C <70–80 · Triglycerides <100 (many target <80) · HDL-C >50 · Triglyceride:HDL ratio <2 — that ratio is a strong practical surrogate for insulin resistance.
High LDL/ApoB drives atherosclerosis. High triglycerides above ~500 mg/dL also risks pancreatitis.
Very low HDL is common on androgens and associated with elevated risk. Very low LDL is generally fine and often therapeutic.
You can order Lipid Panel (Cholesterol, HDL, LDL, Triglycerides) directly through Marek Diagnostics without a doctor's visit — drawn at any Quest Diagnostics location in the US. Code CAMERON applies 10% off automatically.
Where this goes next
This page is the free framework. The protocol itself — the dosing, the order to correct things in, the week-by-week schedule and what to retest — is a lesson inside Skool.